Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Melanoma 1Leukemia, Promyelocytic, Acute 1Childhood Acute Promyelocytic Leukemia With PML-RARA 1Carcinoma, Basal Cell 1Breast Neoplasms 1

Interventions

HhAntag691 21Biopsy 11Imiquimod 10Aminolevulinic Acid 9sonidegib 8Photochemotherapy 8Nivolumab 81-phenyl-3,3-dimethyltriazene 7methyl 5-aminolevulinate 6cemiplimab 6Surgical Procedures, Operative 5Specimen Handling 5Radiotherapy 5Itraconazole 5pembrolizumab 4daromun 4Mohs Surgery 4Magnetic Resonance Spectroscopy 4Ipilimumab 4Curettage 4Tomography, Optical Coherence 3Standard of Care 3Niacinamide 3Microscopy, Confocal 3IPI-926 3CTLA-4 Antigen 33-ingenyl angelate 3tazarotene 2talimogene laherparepvec 2relatlimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Basal Cell × arsenous acid × Clear all
NCT02699723 2020-10-22

Arsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell Cancer

Stanford University

Phase EARLY_PHASE1 Withdrawn
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡